| Date | Title | Description | Source |
| 30.04.2024 | WuXi Biologics Releases 2023 ESG Report Demonstrating Strong... | The Company demonstrated a deep commitment to achieving ESG success in partnership with global clien... | en.prnasia... |
| 26.03.2024 | WuXi Biologics Reports Solid 2023 Annual Results | Revenue Increased by 11.6% Y-o-Y to RMB17,034.3 Million
Gross Profit Rose by 1.5% to RMB6,827.9 Mill... | en.prnasia... |
| 25.03.2024 | WuXi XDC Delivers Outstanding Performance in 2023 with over ... | Revenue reached RMB 2,124 million, an increase of 114% compared with Year 2022
Adjusted net profit r... | en.prnasia... |
| 05.03.2024 | WuXi Biologics Achieves Leadership Level in 2023 CDP Climate... | SHANGHAI, March 5, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading g... | en.prnasia... |
| 21.02.2024 | WuXi Biologics Recognized as Both Industry and Regional ESG ... | Named Top-Rated for fourth consecutive year
Committed to generating long-term value for all stakehol... | en.prnasia... |
| 31.01.2024 | WuXi XDC Enters into Partnership with Multitude Therapeutics... | SHANGHAI, Jan. 31, 2024 /PRNewswire/ -- WuXi XDC (2268.HK), a leading global Contract Research, Deve... | en.prnasia... |
| 31.01.2024 | WuXi Biologics Successfully Completes First 1,6000L Manufact... | - First manufacturing run successful for MFG7 facility at the Ireland site
- Largest manufacturing s... | en.prnasia... |
| 25.01.2024 | WuXi Biologics Launches WuXia ADCC PLUS™ for the Development... | - WuXiaADCC PLUSTM is designed to meet the market need for improved antibody therapeutic efficacy by... | en.prnasia... |
| 24.01.2024 | WuXi XDC and Celltrion Sign MOU for Integrated Services for ... | SHANGHAI and INCHEON, South Korea, Jan. 24, 2024 /PRNewswire/ -- WuXi XDC(2268.HK), a leading global... | en.prnasia... |
| 17.01.2024 | WuXi Biologics Granted U.S. Patent for Proprietary Bispecifi... | SHANGHAI, Jan. 17, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading g... | en.prnasia... |
| 08.01.2024 | WuXi Biologics to Increase Manufacturing Capacity in Massach... | The added capacity will further enhance WuXi Biologics' commercial manufacturing capabilities in the... | en.prnasia... |
| 13.12.2023 | WuXi Vaccines Wins Second Consecutive "Best Vaccine CMO... | SINGAPORE, Dec. 13, 2023 /PRNewswire/ -- WuXi Vaccines, a leading global vaccine Contract Developmen... | en.prnasia... |
| 08.12.2023 | WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Su... | Ranked in top 1% of the over 100,000 companies evaluated
Recognized for outstanding performance acro... | en.prnasia... |
| 06.12.2023 | WuXi Vaccines Passes First GMP Audit by a Global Vaccine Lea... | SUZHOU, China, Dec. 6, 2023 /PRNewswire/ -- WuXi Vaccines, a leading global vaccine CDMO (Contract D... | en.prnasia... |
| 22.11.2023 | WuXi Biologics Successfully Implemented a Fully Integrated C... | By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance ... | en.prnasia... |
| 17.11.2023 | WuXi XDC Successfully Listed on the Main Board of Hong Kong ... | HONG KONG, Nov. 17, 2023 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Com... | en.prnasia... |
| 08.11.2023 | WuXi Biologics Receives AAA MSCI ESG Rating | SHANGHAI, Nov. 8, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading gl... | en.prnasia... |
| 20.10.2023 | WuXi XDC Named Best CDMO Winner at 2023 World ADC Awards | SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract, Research, Development... | en.prnasia... |
| 18.10.2023 | WuXi XDC and HKSTP Join Forces to Promote Development of Bio... | Hong Kong Science and Technology Parks Corporation (HKSTPC) and WuXi XDC signed a cooperation framew... | en.prnasia... |
| 17.10.2023 | WuXi Biologics Launches New High-Productivity Bioprocessing ... | WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to ... | en.prnasia... |
| 02.10.2023 | WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA... | WUXI, China, Oct. 2, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading... | en.prnasia... |
| 26.09.2023 | WuXi Vaccines Launches Its First Vaccines CDMO Site in China | SUZHOU, China, Sept. 26, 2023 /PRNewswire/ -- WuXi Vaccines, a leading contract development and manu... | en.prnasia... |
| 20.09.2023 | WuXi XDC Launches New Commercial Manufacturing Facilities | New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconju... | en.prnasia... |
| 11.08.2023 | WuXi XDC and Boostimmune Sign MOU for Integrated Services | SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development an... | en.prnasia... |
| 11.08.2023 | WuXi Biologics and Boostimmune Sign MOU for Exclusive Resear... | SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading g... | en.prnasia... |
| 27.06.2023 | Pharmadule Morimatsu and WuXi Biologics Reached Global Strat... | SHANGHAI, June 27, 2023 /PRNewswire/ -- June 26th, 2023, Pharmadule Morimatsu and WuXi Biologics off... | en.prnasia... |
| 01.06.2023 | WuXi Biologics to Increase Manufacturing Capacity in Germany | - In response to global clients' increasing demand for contract manufacturing services, WuXi Biologi... | en.prnasia... |
| 22.05.2023 | WuXi Biologics Receives 2023 ISPE Facility of the Year Award... | DUNDALK, Ireland, May 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a l... | en.prnasia... |
| 16.05.2023 | WuXi Biologics Announces Manufacturing Partnership with Infl... | WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class m... | en.prnasia... |
| 28.04.2023 | WuXi Biologics Releases 2022 ESG Report Detailing Its Contin... | The Report outlines new goals of net-zero GHG emissions across all operations by 2050 and a 10% redu... | en.prnasia... |
| 28.03.2023 | WuXi Biologics Congratulates Amicus Therapeutics on European... | WUXI, China, March 28, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leadi... | en.prnasia... |
| 22.03.2023 | WuXi Biologics Reports Remarkable 2022 Annual Results | Revenue Increased by 48.4% Y-o-Y to RMB15,268.7 Million
Gross Profit Increased by 39.2% Y-o-Y to RMB... | en.prnasia... |
| 05.01.2023 | WuXi Biologics and GSK Enter into License Agreement on Multi... | WuXi Biologics will provide an exclusive license to GSK for one preclinical bi-specific T cell engag... | en.prnasia... |
| 26.12.2022 | GeneQuantum and WuXi XDC have entered into strategic coopera... | SUZHOU, China, Dec. 26, 2022 /PRNewswire/ -- GeneQuantum Healthcare (GQ), a global innovative biotec... | einpresswi... |
| 16.12.2022 | WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Co... | SHANGHAI, Dec. 16, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio", 2269.HK), a leading gl... | en.prnasia... |
| 16.12.2022 | WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Co... | SHANGHAI, Dec. 15, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio", 2269.HK), a leading gl... | einpresswi... |
| 27.10.2022 | WuXi Biologics Provides Corporate Updates | SHANGHAI, Oct. 27, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading ... | en.prnasia... |
| 26.10.2022 | WuXi Biologics Announces GMP Release of 48,000L Commercial D... | - The 11th drug substance facility is released for cGMP operation in the WuXi Biologics' global manu... | en.prnasia... |
| 24.10.2022 | WuXi Biologics Released a New cGMP Drug Product Manufacturin... | WuXi Biologics adds further capacity and capability for drug product fill & finish, providing gl... | en.prnasia... |
| 24.10.2022 | WuXi Biologics Released a New cGMP Drug Product Manufacturin... | WuXi Biologics adds further capacity and capability for drug product fill & finish, providing gl... | einpresswi... |
| 14.10.2022 | WuXi Biologics Receives "Best CDMO Award of the Year&qu... | SHANGHAI, Oct. 13, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading g... | einpresswi... |
| 14.10.2022 | Will the Taiwan Semiconductor Manufacturing Company of Drugs... | On Aug. 25, President Biden signed the monumental $52.7 billion CHIPS and Science Act into law. The ... | lawfareblo... |
| 14.10.2022 | WuXi Biologics Receives "Best CDMO Award of the Year&qu... | SHANGHAI, Oct. 14, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading g... | en.prnasia... |
| 12.10.2022 | WuXi Biologics and Toregem BioPharma Sign MOU for Developmen... | SHANGHAI, Oct. 11, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading g... | en.prnasia... |
| 10.10.2022 | Indian manufacturer under scrutiny after cough syru... | LONDON — Back when Jack O’Meara and Quin Wills were initially setting up Ochre Bio, they jumped from... | endpts.com... |
| 10.10.2022 | J&J's Janssen unveils PhII ulcerative colitis dat... | As J&J’s Janssen has worked to expand the use of Tremfya over the past few years, its latest ... | endpts.com... |
| 10.10.2022 | After $10B in market value lost, China's WuXi Biologi... | WuXi Biologics has cause to celebrate as it finds itself removed from the US Department of ... | endpts.com... |
| 10.10.2022 | The crown jewel in Merck’s $11.5B Acceleron buyout just ... | Merck consistently spotlighted the multibillion-dollar sales potential of sotatercept, ... | endpts.com... |
| 10.10.2022 | WuXi Biologics Co., Ltd. Removed from Unverified List | WUXI, China, Oct. 10, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio", 2269.HK), a leading... | en.prnasia... |
| 29.09.2022 | WuXi Biologics Topped Off the Steel on its Commercial Bioman... | WORCESTER, Mass., Sept. 29, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ... | en.prnasia... |
| 20.09.2022 | WuXi Biologics' Drug Substance and Drug Product Facilities A... | WUXI, China, Sept. 20, 2022 /PRNewswire/ --WuXi Biologics ("WuXi Bio") (2269.HK), a leadin... | en.prnasia... |
| 31.08.2022 | WuXi Biologics Announces GMP Release of Its First North Amer... | CRANBURY, N.J., Aug. 31, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a glo... | en.prnasia... |
| 17.08.2022 | WuXi Biologics Reports Strong 2022 Interim Results | Revenue Increased by 63.5% Y-o-Y to RMB7,206.4 Million
Gross Profit Increased by 48.6% Y-o-Y to RMB3... | en.prnasia... |
| 17.08.2022 | WuXi Biologics Again Selected as Constituent of FTSE4Good In... | SHANGHAI, Aug. 17, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global le... | en.prnasia... |
| 20.07.2022 | Chinese biotech firm allots $1.4b for Singapore expansion | InvestmentsNews
Thao Lam La · 2d ago · 2 min readChinese biotech firm allots $1.4b for Singapore exp... | techinasia... |
| 19.07.2022 | WuXi Biologics serves up $1.4B expansion of research a... | While WuXi Biologics is continuing to work with US regulators on inspections of its faci... | endpts.com... |
| 19.07.2022 | WuXi Biologics Plans to Build a Comprehensive CRDMO Center i... | This investment will establish a cutting-edge, fully integrated CRDMO center in Singapore, including... | en.prnasia... |
| 12.07.2022 | WuXi Vaccines Received First GMP Certificate of QC Potency L... | - The first GMP certificate that WuXi Vaccines has received from the regulatory agency
- A critical ... | en.prnasia... |
| 08.07.2022 | WuXi XDC and AbTis Sign Memorandum of Understanding for Deve... | SHANGHAI and SEOUL, South Korea, July 8, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Cont... | en.prnasia... |
| 05.07.2022 | WuXi Biologics Extends Capabilities to Include Development a... | WuXi Biologics expands its extensive integrated CRDMO services by offering development and cGMP manu... | en.prnasia... |
| 06.06.2022 | WuXi Biologics Launches First Commercial Drug Product Facili... | WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for cl... | en.prnasia... |
| 28.04.2022 | WuXi Biologics' 2021 ESG Report Reveals Company's Strong Com... | - WuXi Biologics has aligned its ESG strategy with the United Nations Sustainable Development Goals ... | en.prnasia... |
| 15.04.2022 | WuXi Biologics Receives Bioprocessing Excellence Award from ... | SINGAPORE, April 15, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global ... | en.prnasia... |
| 23.03.2022 | WuXi Biologics Achieved Record Growth and Profitability in 2... | Banner Year for Commercial Manufacturing
Revenue Increased by 83.3% Y-o-Y to RMB10,290.1 Million
Gro... | en.prnasia... |
| 14.03.2022 | WuXi Biologics Recognized as 2022 Top-Rated ESG Company by S... | SHANGHAI, March 14, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global C... | en.prnasia... |
| 02.03.2022 | WuXi Biologics Wins CMO Leadership Awards in All Six Core Ca... | SHANGHAI, March 2, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CR... | en.prnasia... |
| 08.02.2022 | WuXi Biologics Statement | SHANGHAI, Feb. 8, 2022 /PRNewswire/ -- We have been made aware of a recent U.S. Commerce Department ... | en.prnasia... |
| 18.01.2022 | WuXi Biologics Cayman : Completes GMP Inspection by South Ko... | WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug S... | marketscre... |
| 18.01.2022 | WuXi Biologics Completes GMP Inspection by South Korea's Min... | WuXi Biologics completes the first GMP inspection in 2022, demonstrating the company's premier quali... | en.prnasia... |
| 07.01.2022 | WuXi Biologics Cayman : Vaccines and BravoBio Sign Letter of... | WuXi Vaccines and BravoBio Sign Letter of Intent for Long-Term Collaboration - Accelerating Developm... | marketscre... |
| 28.12.2021 | WuXi Biologics Cayman : and ImmuneOncia Sign MOU for Develop... | WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispeci... | marketscre... |
| 22.12.2021 | WuXi Biologics Cayman : Wins 2021 Hong Kong Corporate Govern... | WuXi Biologics Wins 2021 Hong Kong Corporate Governance Award
Hong Kong, December 21, 2021 - WuXi Bi... | marketscre... |
| 23.11.2021 | WuXi Biologics Cayman : First GMP Production at 24,000L Line... | First GMP Production at 24,000L Line of MFG5 Facility Successfully Completed at WuXi Biologics
MFG5 ... | marketscre... |
| 01.11.2021 | WuXi Biologics Launches a New GMP Commercial Drug Product Fa... | Enhances drug product services for projects at various stages, with an emphasis on late and commerci... | en.prnasia... |
| 28.10.2021 | WuXi Biologics Completes GMP Inspection by Health Canada for... | - Successfully completed nearly 20 regulatory inspections in total, including 13 regulatory inspecti... | en.prnasia... |
| 01.09.2021 | WuXi Biologics Received First Manufacturing License from Jap... | Successfully completed 12 regulatory inspections so far this year
WUXI, China, Sept. 1, 2021 /PRNews... | en.prnasia... |
| 23.08.2021 | WuXi Biologics Reports Strong 2021 Interim Results | Revenue Increases by 126.7% Y-o-Y to RMB4,406.8 Million
Gross Profit Grows by 191.7% Y-o-Y to RMB2,2... | en.prnasia... |
| 02.08.2021 | WuXi Biologics Biosafety Testing Facility Received Second EM... | SUZHOU, China, Aug. 2, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a globa... | en.prnasia... |
| 26.07.2021 | WuXi Biologics : Received Commercial Manufacturing License f... | First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quali... | marketscre... |
| 26.07.2021 | WuXi Biologics Received Commercial Manufacturing License fro... | First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quali... | en.prnasia... |
| 15.07.2021 | WuXi Biologics Cayman : Adlai Nortye Raises $100 Million in ... | NEW JERSEY and HANGZHOU, CHINA, Jul 15, 2021 - (ACN Newswire) - - Adlai Nortye Ltd. (hereinafter ref... | marketscre... |
| 10.06.2021 | WuXi XDC and LegoChem Biosciences Signed Memorandum of Under... | WUXI, China and DAEJEON, South Korea, June 10, 2021 /PRNewswire/ -- WuXi XDC ("XDC"), a gl... | en.prnasia... |
| 27.05.2021 | WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnersh... | SHANGHAI and ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (226... | en.prnasia... |
| 14.05.2021 | WuXi Biologics and WuXi STA Jointly Established WuXi XDC to ... | WUXI, China, May 14, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global ... | en.prnasia... |
| 07.05.2021 | WuXi Biologics Completed Three Acquisitions to Enhance its G... | SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global comp... | en.prnasia... |
| 18.03.2021 | Merck KGaA adds 350 workers at French site to build capac... | Germany’s Merck KGaA has seen a growth spurt in recent months driven by sky-high demand for Cov... | endpts.com... |
| 18.03.2021 | Pfizer lays down its hand on Chinese biosims, offloading... | Pfizer is in downsizing mode after a hefty spinoff of its Upjohn generics unit and a full-sca... | endpts.com... |
| 19.01.2021 | Oxford BioTherapeutics Designates Second Bispecific Antibody... | OXFORD, United Kingdom and SAN JOSE, Calif. and SHANGHAI, China, Jan. 19, 2021 (GLOBE NEWSWIRE) -- W... | alsaventur... |
| 21.12.2020 | Looking to build a 'dual sourcing' supply chain, WuXi Bi... | Biologics have been particularly hot in 2020 with big drugmakers looking to bolster their... | endpts.com... |
| 23.10.2020 | Power Moves: KOP life sciences hub Discovery Labs adds a top... | Power Moves is a column where we chart the comings and goings of talent across the region. Got a new... | technical.... |
| 16.03.2020 | Ally Bridge Portfolio News – WuXi Biologics and Vir Biotechn... | SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a le... | ally-bridg... |
| 24.02.2020 | Invetx Announces $15 million Series A Financing and Industry... | Anterra Capital leads financing to advance Invetx’s pipeline of veterinary biologic drugs leveraging... | anterracap... |
| 05.08.2019 | How Biotech Startup Funding Will Change in the Next 10 Years | Back when YC was getting started about 10 years ago, Paul Graham wrote some essays that predicted th... | ycombinato... |
| - | Exelixis Enters into Exclusive License Agreement with WuXi B... | ALAMEDA, Calif. & SHANGHAI--(BUSINESS WIRE)--Mar 8, 2021--
Exelixis, Inc. (Nasdaq: EXEL) and WuX... | oaoa.com/n... |
| - | S&P 500 jumps 1% for fresh closing record, Nasdaq pops 1... | Stocks rose Thursday, pushing the S&P 500 and Nasdaq Composite back to record highs, as hope ove... | cnbc.com/2... |
| - | How Biotech Startup Funding Will Change in the Next 10 Years | Back when YC was getting started about 10 years ago, Paul Graham wrote some essays that predicted th... | blog.ycomb... |
| - | Japan stocks retreat from record highs; China trade data bet... | This is CNBC’s live blog covering Asia-Pacific markets.
Japan stock indexes retreated from record hi... | cnbc.com/2... |
